Cost-Efficient Early Diagnostic Tool for Lung Cancer: Explainable AI in Clinical Systems
Technology in Cancer Research & Treatment · 2025
DOI: 10.1177/15330338251370239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2025. Verfasst von Anu Maria Sebastian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science and Engineering, Indian Institute of Information Technology, Kottayam, Kerala, India. Hauptthemen laut MEDLINE: Lung Neoplasms, Early Detection of Cancer, Artificial Intelligence. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Lung cancer has the highest mortality rate among all cancer types globally, largely due to delayed or ineffective diagnosis and treatment. Radiomics is commonly used to diagnose lung cancer, especially in later stages or during routine screenings. However, frequent radiological imaging poses health risks, and while advanced diagnostic alternatives exist, they are often costly and accessible only to a limited, privileged population. Leveraging clinical data using machine learning (ML) and artificial intelligence (AI) enables a safer, more inclusive, and affordable solution. Due to a lack of interpretability, AI-based models for cancer diagnosis are less adopted by clinicians.
Methods
This study introduces a safe, inclusive, and cost-effective lung cancer diagnostic method using an explainable AI (XAI) model built on routine clinical data. It employs a stacking ensemble of Artificial Neural Network (ANN) and Deep Neural Network (DNN) to match the diagnostic performance of clean-data DNN models. By incorporating rare medical cases through Adaptive Synthetic Sampling (ADASYN), the model reduces the risk of missing challenging, rare-case diagnoses.
Results
The proposed XAI model demonstrates strong performance with an accuracy of 0.8558, AUC of 0.8600, precision of 0.8092, recall of 0.9282, and F1-score of 0.8646, notably improving rare case detection by over 50%. SHapley additive exPlanations(SHAP)-based interpretability highlights Erythrocyte sedimentation rate(ESR), intoxication-related factors, hemoglobin levels, and neutrophil counts as key features. The model also reveals associations, such as a link between heavy tobacco use and elevated ESR. Counterfactual explanations help identify features contributing to misdiagnoses by exposing sources of confusion in the model's decisions.
Conclusion
Given the limited dataset size and geographic constraints, this research should be viewed as a prototype and in its current form, the model is best suited as a pre-screening tool to support early detection. With training on larger and more diverse datasets, the model has strong potential to evolve into a robust and scalable diagnostic solution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Computer Science and Engineering, Indian Institute of Information Technology, Kottayam, Kerala, India.
- Department of Computer Science, Cochin University of Science and Technology, Kochi, Kerala, India.
- Department of Pulmonary Medicine, Institute of Chest Diseases, Government Medical College, Kozhikode, Kerala, India.
- School of Computing and Information Systems, The University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: Anu Maria Sebastian
Zitieren
APA
Sebastian, A. M., Peter, D., Rajagopal, T. P., & Sebastian, R. A. (2025). Cost-Efficient Early Diagnostic Tool for Lung Cancer: Explainable AI in Clinical Systems. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338251370239
Vancouver
Sebastian AM, Peter D, Rajagopal TP, Sebastian RA. Cost-Efficient Early Diagnostic Tool for Lung Cancer: Explainable AI in Clinical Systems. Technology in Cancer Research & Treatment. 2025. doi:10.1177/15330338251370239
BibTeX
@article{Sebastian2025,
author = {Sebastian, Anu Maria and Peter, David and Rajagopal, T P and Sebastian, Rinu Ann},
title = {Cost-Efficient Early Diagnostic Tool for Lung Cancer: Explainable AI in Clinical Systems},
journal = {Technology in Cancer Research & Treatment},
year = {2025},
doi = {10.1177/15330338251370239}
}
EUVIMED